OTC : BMXXY
$0.17 (2.02%)
OTC
Pierre Boulud
Medical - Diagnostics & Research
Healthcare
BMXXY
15078
FR
USD
0.10
2.30
1.44
0.58
0.25
$4.07B
2.15
1.99
14.62
0.50
$0.32
$381.81M
11.59%
15.21%
11.01%
8.12%
18.46
0.81
0.81
4/5
0 Analysts
%
6.32
9/9
$1.47B
$5.69B
$1.39B
$1.14B
$8.36B
2.09
9.12
2.30
11.01%
7.59%
5.39%
6.81%
$56.78
226 days
| Name | Title |
|---|---|
| Guillaume Bouhours | Executive VP of Finance, Purchasing and Information Systems & CFO |
| Pierre Charbonnier | Executive Vice President of Global Quality, Manufacturing & Supply Chain |
| Yasha Mitrotti | Executive Vice President of Industrial Applications |
| Audrey Dauvet | Executive Vice President of Legal, Corporate Integrity & Public Affairs |
| Celine Roger-Dalbert | Executive Vice President of Research & Development |
| Valerie Leylde | Executive Vice President of Human Resources, Communications & CSR |
| Charles K. Cooper | Executive VP of Medical Affairs & Chief Medical Officer |
| Frederic Beseme | Head of CSR |
| Jennifer Zinn | Executive Vice President of Clinical Operations |
| Pierre Boulud | Chief Executive Officer |
No votes yet today — be the first to share your view!
About bioMérieux S.A. (OTC:BMXXY) Stock
bioMérieux S.A. is a global leader in the development and production of in vitro diagnostic solutions, primarily aimed at detecting infectious diseases. Its operations span the Americas, Europe, the Middle East, Africa, and the Asia Pacific regions. The company provides sophisticated diagnostic platforms that analyze biological specimens to pinpoint infectious diseases, cardiovascular conditions, and various cancers. Additionally, it offers microbiological testing for quality control in manufacturing, serving the food, pharmaceutical, cosmetics, and veterinary industries. Its diverse clientele encompasses clinical and hospital laboratories, medical practitioners, blood banks, and industrial control facilities. Founded in 1963, the company, previously known as B-D Mérieux, maintains its hea ... dquarters in Marcy l'Etoile, France. bioMérieux S.A. operates as a subsidiary of Institut Mérieux SA.
Frequently Asked Questions
What is the current bioMérieux S.A. (BMXXY) stock price?
bioMérieux S.A.(OTC:BMXXY) stock price is $8.82 in the last trading session. During the trading session, BMXXY stock reached the peak price of $14.62 while $7.12 was the lowest point it dropped to. The percentage change in BMXXY stock occurred in the recent session was 2.02% while the dollar amount for the price change in BMXXY stock was $0.17.
BMXXY's industry and sector of operation?
The OTC listed BMXXY is part of Medical - Diagnostics & Research industry that operates in the broader Healthcare sector.
Who are the executives of BMXXY?
Guillaume Bouhours
| Executive VP of Finance, Purchasing and Information Systems & CFO
Pierre Charbonnier
| Executive Vice President of Global Quality, Manufacturing & Supply Chain
Yasha Mitrotti
| Executive Vice President of Industrial Applications
Audrey Dauvet
| Executive Vice President of Legal, Corporate Integrity & Public Affairs
Celine Roger-Dalbert
| Executive Vice President of Research & Development
How many employees does BMXXY have?
Number of BMXXY employees currently stands at 15078. BMXXY operates from 376 Chemin De l’Orme, Marcy l'Étoile, ARA 69280, FR.
Link for BMXXY official website?
Official Website of BMXXY is: https://www.biomerieux.com
How do I contact BMXXY?
BMXXY could be contacted at phone #33 4 78 87 20 00 and can also be accessed through its website. BMXXY operates from 376 Chemin De l’Orme, Marcy l'Étoile, ARA 69280, FR.
How many shares of BMXXY are traded daily?
The average number of BMXXY shares traded daily for last 3 months was 3.02K.
What is the market cap of BMXXY currently?
The market value of BMXXY currently stands at $10.4B with its latest stock price at $8.82